Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2 (eBook, PDF)

Redaktion: de Velde, Steef van; Schornagel, J. H.

• Format: PDF

Produktbeschreibung

Zur Zeit liegt uns keine Inhaltsangabe vor.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Springer New York
• Seitenzahl: 358
• Erscheinungstermin: 11. November 2013
• Englisch
• ISBN-13: 9781489902184
• Artikelnr.: 44045541

Inhaltsangabe

Synthesis and Activity of Platinum Compounds.- NMR Spectroscopy of Platinum Drugs: From DNA to Body Fluids.- Trans-Diamminedichloroplatinum (II) Is Not an Antitumor Drug: Why?.- Iminoethers as Carrier Ligands: A Novel trans-Platinum Complex Possessing in Vitro and in Vivo Antitumor Activity.- Molecular Dynamics Simulations on Cisplatin Adducts with Dinucleotides.- Orally Active DACH-Pt (IV) Compounds.- Clinical Pharmacology.- Pharmacokinetic - Pharmacodynamic Relationships.- Clinical Pharmacology of Carboplatin Administered in Alternating Sequence with Paclitaxel in Patients with Non-Small Cell Lung Cancer: A European Cancer Centre (ECC) Study.- The Clinical Development of the Oral Platinum Anticancer Agent JM216.- Biochemistry and Molecular Pharmacology.- Membrane Transport of Platinum Compounds.- Detection of Adducts Formed upon Treatment of DNA with Cisplatin and Carboplatin.- Detection of Platinum Lesions at the Nucleotide Level in Cells using Single Strand Ligation PCR.- A Review of the Modulation of Cisplatin Toxicities by Chemoprotectants.- Combination Therapy with Cisplatinum and EGF Receptor Blockade.- Clinical Studies.- Oxaliplatin: Update on a Active and Safe Dach Platinum Complex.- Combination of Different Platinum Compounds: Issues, Strategies and Experience.- Phase I and II Studies with Lobaplatin.- Phase I Trials of Ormaplatin (NSC 363812).- 254-S, NK121 and TRK710.- Clinical Trials of Oxaliplatin and DWA2114R.- Incorporating Assessments of Sequence-Dependence in Developmental Studies of Combination Chemotherapy Regimens Containing New Agents and Platinum Compounds.- Review of Carboplatin-Based High-Dose Chemotherapy Combinations in the Autotransplant Setting.- Treatment Intensification in Germ-Cell Tumours.- IL-1? Enhancement of Platinum-MediatedAnti-Tumor Activity.- Non-Platinum Metal Complexes.- Overview of Tumor-Inhibiting Non-Platinum Complexes.- How does Platinum Kill the Cell?.- The Cisplatin-Induced Cellular Injury Response.- The Interaction of Cisplatin with Signal Transduction Pathways and the Regulation of Apoptosis.- Cell Cycle Checkpoints and Cancer Chemotherapy.- Controversy Session: Cisplatin vs Carboplatin?.- Carboplatin versus Cisplatin in the Chemotherapy of Solid Tumors: Pro-Carboplatin.- Cisplatin and Carboplatin in Testis and Ovarian Cancer: Pro Cisplatin.- Resistance.- Hypersensitivity to Cisplatin in Mouse Leukemia L1210/0 Cells: An XPG DNA Repair Defect.- DNA Repair and the Carrier Ligand Specificity of Platinum Resistance.- Transcription Factor Differences in Cisplatin Resistant Cells.